Clinical Data of 26 Patients With Diffuse Large B-Cell Lymphoma
| Case No. . | Age/Sex . | Ann Arbor Stage . | Primary/Recurrent . | Follow-up (mo) . | Survival Status . | Site of the Specimen . |
|---|---|---|---|---|---|---|
| . | . | (I-IV) . | . | . | . | . |
| 1 | 64/M | IV | P | 20 | DOI | Lymph node |
| 2 | 70/F | II | P | 31 | DOL | Mediastinum |
| 3 | 84/M | III | P | 2 | DOL | Lymph node |
| 4 | 50/M | I | P | 60 | NED | Pharyngeal tonsil |
| 5 | 77/F | II | R | 12 | DOL | Lymph node |
| 6 | 59/F | I | R | 125 | NED | Lymph node |
| 7 | 53/M | II | P | 3 | NED | Lymph node |
| 8 | 50/M | II | P | 10 | NED | Lymph node |
| 9 | 64/F | III | P | 36 | AWD | Lymph node |
| 10 | 60/F | III | P | 31 | NED | Lymph node |
| 11 | 47/F | I | P | 36 | NED | Lymph node |
| 12 | 25/M | IV | P | 29 | DOL | Spleen |
| 13 | 69/F | IV | P | 11 | DOL | Small bowel |
| 14 | 35/F | I | P | 54 | NED | Lymph node |
| 15 | 38/M | I | P | 51 | DOI | Lymph node |
| 16 | 59/F | I | R | 29 | DOI | Breast |
| 17 | 71/F | III | P | 1 | DOL | Lymph node |
| 18 | 47/M | IV | P | 8 | DOL | Mesentery |
| 19 | 59/F | I | R | 36 | DOL | Skin |
| 20 | 37/M | II | R | 10 | DOL | Lymph node |
| 21 | 81/F | I | R | 20 | DOI | Stomach |
| 22 | 70/M | IV | P | 0 | DOL | Mesentery |
| 23 | 51/F | IV | P | 59 | NED | Lymph node |
| 24 | 52/F | I | P | 26 | NED | Spleen |
| 25 | 62/F | IV | P | 0 | DOL | Lymph node |
| 26 | 54/M | II | P | 72 | NED | Lymph node |
| Case No. . | Age/Sex . | Ann Arbor Stage . | Primary/Recurrent . | Follow-up (mo) . | Survival Status . | Site of the Specimen . |
|---|---|---|---|---|---|---|
| . | . | (I-IV) . | . | . | . | . |
| 1 | 64/M | IV | P | 20 | DOI | Lymph node |
| 2 | 70/F | II | P | 31 | DOL | Mediastinum |
| 3 | 84/M | III | P | 2 | DOL | Lymph node |
| 4 | 50/M | I | P | 60 | NED | Pharyngeal tonsil |
| 5 | 77/F | II | R | 12 | DOL | Lymph node |
| 6 | 59/F | I | R | 125 | NED | Lymph node |
| 7 | 53/M | II | P | 3 | NED | Lymph node |
| 8 | 50/M | II | P | 10 | NED | Lymph node |
| 9 | 64/F | III | P | 36 | AWD | Lymph node |
| 10 | 60/F | III | P | 31 | NED | Lymph node |
| 11 | 47/F | I | P | 36 | NED | Lymph node |
| 12 | 25/M | IV | P | 29 | DOL | Spleen |
| 13 | 69/F | IV | P | 11 | DOL | Small bowel |
| 14 | 35/F | I | P | 54 | NED | Lymph node |
| 15 | 38/M | I | P | 51 | DOI | Lymph node |
| 16 | 59/F | I | R | 29 | DOI | Breast |
| 17 | 71/F | III | P | 1 | DOL | Lymph node |
| 18 | 47/M | IV | P | 8 | DOL | Mesentery |
| 19 | 59/F | I | R | 36 | DOL | Skin |
| 20 | 37/M | II | R | 10 | DOL | Lymph node |
| 21 | 81/F | I | R | 20 | DOI | Stomach |
| 22 | 70/M | IV | P | 0 | DOL | Mesentery |
| 23 | 51/F | IV | P | 59 | NED | Lymph node |
| 24 | 52/F | I | P | 26 | NED | Spleen |
| 25 | 62/F | IV | P | 0 | DOL | Lymph node |
| 26 | 54/M | II | P | 72 | NED | Lymph node |
Abbreviations: M, male; F, female; P, primary; R, recurrent; AWD, alive with disease; DOI, dead of intercurrent disease; DOL, dead of lymphoma; NED, no evidence of disease.